1. |
Momeni P, Glockner G, Schmidt O,et al. Mutations in a new gene, encoding a zinc-finger protein, cause trichorhinophalangeal syndrome type I. Nat Genet 2000; 24: 71-4.
|
2. |
Malik TH, Shoichet SA, Latham P,et al. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. EMBO J 2001; 20: 1715-25.
|
3. |
Kouros-Mehr H, Slorach EM, Sternlicht MD,et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006; 127: 1041-55.
|
4. |
Gai Z, Zhou G, Gui T,et al. Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression. J Am Soc Nephrol 2010; 21: 1468-76.
|
5. |
Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet 2011; 378: 1812-23.
|
6. |
Prat A, Parker JS, Karginova O,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.
|
7. |
Buckley NE, Mullan PB. BRCA1—conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer. Stem Cell Rev 2012; 8: 982-93.
|
8. |
Proia TA, Keller PJ, Gupta PB,et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011; 8: 149-63.
|
9. |
Wu ZQ, Li XY, Hu CY,et al. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 2012; 109: 16654-9.
|
10 |
Dejeux E, Ronneberg JA, Solvang H,et al. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol Cancer 2010; 9: 68.
|
11 |
Bloushtain-Qimron N, Yao J, Snyder EL,et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA 2008; 105: 14076-81.
|
12 |
Bierie B, Stover DG, Abel TW,et al. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 2008; 68: 1809-19.
|
13 |
Acharyya S, Oskarsson T, Vanharanta S,et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012; 150: 165-78.
|
14 |
van't Veer LJ, Dai H, van de Vijver MJ,et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6.
|
15 |
Wang Y, Klijn JG, Zhang Y,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365: 671-9.
|
16 |
Stinson S, Lackner MR, Adai AT,et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal 2011; 4: pt5.
|
17 |
Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010; 2: a002915.
|
18 |
Lin K, Baritaki S, Militello L, Malaponte G,et al. The role of B-RAF mutations in melanoma and the induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN circuit. Genes Cancer 2010; 1: 409-20.
|
19 |
Lambertini E, Lolli A, Vezzali F,et al. Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells. BMC Cancer 2012; 12: 445.
|
20 |
Chen JQ, Litton J, Xiao L,et al. Quantitative immunohisto- chemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Horm Cancer 2010; 1: 21-33.
|
21 |
Kouros-Mehr H, Kim JW, Bechis SK,et al. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 2008; 20: 164-70.
|
22 |
Albergaria A, Paredes J, Sousa B,et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res 2009; 11: R40.
|
23 |
Yoon NK, Maresh EL, Shen D,et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol 2010; 41: 1794-801.
|
24 |
Tkocz D, Crawford NT, Buckley NE,et al. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. Oncogene 2012; 31: 3667-78.
|
25 |
Ray PS, Wang J, Qu Y,et al. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res 2010; 70: 3870-6.
|
26 |
Fan C, Oh DS, Wessels L,et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006; 355: 560-9.
|